Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages 611-615

  Laine, Outi ^a   Joutsi Korhonen, Lotta ^b   Mäkelä, Satu ^a   Mikkelsson, Jussi ^c   Pessi, Tanja ^a,d   Tuomisto, Sari ^a,d   Huhtala, Heini ^d   Libraty, Daniel ^e   Vaheri, Antti ^f   Karhunen, Pekka ^a,d   Mustonen, Jukka ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coagulation; Fibrinolysis; Hantavirus; HPA; Platelet; Polymorphism

Indexed keywords

ALANINE; ALPHA2 INTEGRIN; CREATININE; CYSTEINE; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; GUANINE; PLASMINOGEN ACTIVATOR INHIBITOR; THREONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HANTAVIRUS INFECTION; HETEROZYGOTE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUUMALA HANTAVIRUS INFECTION; SEROLOGY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; GENOTYPE; HANTAVIRUS INFECTIONS; HUMANS; INTEGRIN ALPHA2; KIDNEY; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PUUMALA VIRUS; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84860433469     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.007     Document Type: Article

References (32)

1. O. Vapalahti, J. Mustonen, Å. Lundkvist, H. Henttonen, A. Plyusnin, and A. Vaheri Hantavirus infections in Europe Lancet Infect Dis 3 2003 653 661
2. P. Makary, M. Kanerva, J. Ollgren, M.J. Virtanen, O. Vapalahti, and O. Lyytikainen Disease burden of Puumala virus infections, 1995-2008 Epidemiol Infect 138 2010 1484 1492
3. B. Settergren Nephropathia epidemica (hemorrhagic fever with renal syndrome in Scandinavia) Rev Infect Dis 13 1991 736 744
4. J. Mustonen, J. Partanen, M. Kanerva, K. Pietila, O. Vapalahti, and A. Pasternack Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus Kidney Int 49 1996 217 221
5. S. Makela, M. Hurme, I. Ala-Houhala, J. Mustonen, A.-M. Koivisto, and J. Partanen Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection Nephrol Dial Transplant 16 2001 1368 1373
6. 3 integrin in patients with hemorrhagic fever with renal syndrome and its correlation with disease severity Viral Immunol 21 2008 255 261
7. Z. Liu, M. Gao, Q. Han, S. Lou, and J. Fang Platelet glycoprotein IIb/IIIa (HPA-1 and HPA-3) polymorphisms in patients with hemorrhagic fever with renal syndrome Human Immunol 70 2009 452 456
8. Laine O, Makela S, Mustonen J, Huhtala H, Szanto T, Vaheri A, et al. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res;126:154-8.
9. Laine O, Makela S, Mustonen J, Helminen M, Vaheri A, Lassila R, et al. Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis;22:468-72
10. O. Vapalahti, A. Lundkvist, H. Kallio-Kokko, K. Paukku, I. Julkunen, and H. Lankinen Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells J Clin Microbiol 34 1996 119 125
11. S. Kekomaki, J. Partanen, and R. Kekomaki Platelet alloantigens HPA-1, -2, -3, -5 and -6b in Finns Transfus Med 5 1995 193 198
12. G.R. Kunkel, J.B. Graham, D.M. Fowlkes, and S.T. Lord RsaI polymorphism in von Willebrand factor (vWF) at codon 789 Nucleic Acid Res 18 1990 4961
13. A. Lepantalo, J. Mikkelsson, J.C. Resendiz, L. Viiri, J.T. Backman, and E. Kankuri Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients Thromb Haemost 95 2006 253 259
14. W. Koch, M. Schrempf, A. Erl, J.C. Mueller, P. Hoppmann, and A. Schömig 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries Thromb Haemost 103 2010 1170 1180
15. P.W. Hermans, and J.A. Hazelzet Plasminogen activator inhibitor type 1 gene polymorphism and sepsis Clin Infect Dis 41 Suppl. 7 2005 453 458
16. P.W. Hermans, M.L. Hibberd, R. Booy, O. Daramola, J.A. Hazelzet, and R. de Groot 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group Lancet 354 1999 556 560
17. A.T. Mairuhu, T.E. Setiati, P. Koraka, C.E. Hack, A. Leyte, and S.M. Faradz Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism Thromb J 3 2005 17
18. E.C. Van Gorp, T.E. Setiati, A.T. Mairuhu, C. Suharti, H. Cate, and W.M. Dolmans Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever J Med Virol 67 2002 549 554
19. K. Madach, I. Aladzsity, A. Szilagyi, G. Fust, J. Gal, and I. Penzes 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study Crit Care 14 2010 R79
20. R.F. Kornelisse, J.A. Hazelzet, H.F. Savelkoul, W.C. Hop, M.H. Suur, and A.N. Borsboom The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock J Infect Dis 173 1996 1148 1156
21. B.A. Wills, E.E. Oragui, A.C. Stephens, O.A. Daramola, N.M. Dung, and H.T. Loan Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome Clin Infect Dis 35 2002 277 285
22. J.P. Rerolle, E. Munteanu, M. Drouet, J.C. Szelaq, B. Champtiaux, and F. Yagoubi PAI-1 donor polymorphism influences long-term kidney graft survival Nephrol Dial Transplant 23 2008 3325 3332
23. S. Kathiresan, S.B. Gabriel, Q. Yang, A.L. Lochner, M.G. Larson, and D. Levy Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels Circulation 112 2005 1728 1735
24. M. Campos, W. Sun, F. Yu, M. Barbalic, W. Tang, and L.E. Chambless Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort Blood 117 2011 5224 5230
25. C. Lacquemant, C. Gaucher, C. Delorme, G. Chatellier, Y. Gallois, and M. Rodier Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group Kidney Int 57 2000 1437 1443
26. T. Klemm, A.K. Mehnert, A. Siegemund, T.D. Wiesner, G. Gelbrich, and M. Buchner Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2 Exp Clin Endocrinol Diabetes 113 2005 568 572
27. L. Joutsi-Korhonen, P.A. Smethurst, A. Rankin, E. Grey, M. IJsseldijk, and C.M. Onley The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression Blood 101 2003 4372 4379
28. C. Meisel, J.A. Lopez, and K. Stangl Role of platelet glycoprotein polymorphisms in cardiovascular diseases Naunyn Schmiedebergs Arch Pharmacol 369 2004 38 54
29. C.V. Denis, and D.D. Wagner Platelet adhesion receptors and their ligands in mouse models of thrombosis Arterioscler Thromb Vasc Biol 27 2007 728 739
30. 3 integrins J Virol 73 1999 3951 3959
31. S. Saidi, T. Mahjoub, L.B. Slamia, S.B. Ammou, A.M. Al-Subaie, and W.Y. Almawi Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke Am J Hematol 83 2008 570 573
32. Outinen TK, Makela SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis;10:132